-
Jul 1998
Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes.
J ImmunolBourdette DN, Chou YK, Whitham RH, Buckner JH, Kwon HJ, Nepom GT, Buenafe A, Cooper SA, Allegretta M, Hashim GA, Offner H, Vandenbark AA -
Dec 1996
Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions.
J ImmunolBuckner JH, Kwok WW, Nepom BS, Nepom GT -
Apr 1996
Recognition of altered self major histocompatibility complex molecules modulated by specific peptide interactions.
Eur J ImmunolNepom GT, Ou D, Lybrand TP, DeWeese C, Domeier ME, Buckner JH, Mitchell LA, Tingle AJ
